Teladoc Health (NYSE:TDOC) Shares Up 8.1% - Here's Why

Key Points

• Teladoc Health's stock price rose by 8.1%, reaching a last trading price of $8.85 after a mid-day surge on Tuesday.
• The company reported earnings of ($0.19) per share, exceeding analyst expectations, and projected a negative EPS guidance for Q3 2025 between -0.350 and -0.200.
• Analysts have varied opinions on the stock, with an average rating of "Hold" and a consensus price target of $9.80, reflecting cautious sentiment in the market.

Shares of Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) shot up 8.1% during mid-day trading on Tuesday . The stock traded as high as $8.75 and last traded at $8.85. 3,787,109 shares traded hands during trading, a decline of 43% from the average session volume of 6,661,161 shares. The stock had previously closed at $8.19.

Wall Street Analysts Forecast Growth

TDOC has been the topic of a number of recent research reports. Evercore ISI upped their target price on Teladoc Health from $7.00 to $8.00 and gave the company an "in-line" rating in a research note on Wednesday, July 9th. Truist Financial reduced their target price on Teladoc Health from $10.00 to $9.00 and set a "hold" rating on the stock in a research note on Tuesday, May 27th. Bank of America reduced their target price on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating on the stock in a research note on Wednesday, May 28th. Finally, Mizuho initiated coverage on Teladoc Health in a research note on Friday, July 25th. They issued a "neutral" rating and a $10.00 target price on the stock. Six analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $9.80.

Teladoc Health Price Performance

The company has a fifty day simple moving average of $7.65 and a two-hundred day simple moving average of $7.62. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.58 and a current ratio of 2.67. The company has a market capitalization of $1.48 billion, a price-to-earnings ratio of -7.05 and a beta of 1.84.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share for the quarter, beating the consensus estimate of ($0.27) by $0.08. The company had revenue of $631.90 million during the quarter, compared to the consensus estimate of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.Teladoc Health's revenue was down 1.6% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.38) EPS. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. As a group, research analysts anticipate that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Institutional Trading of Teladoc Health

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Marex Group plc acquired a new stake in shares of Teladoc Health during the 2nd quarter worth $488,000. State of Wyoming increased its holdings in shares of Teladoc Health by 46.6% during the 2nd quarter. State of Wyoming now owns 77,447 shares of the health services provider's stock worth $675,000 after buying an additional 24,626 shares during the last quarter. Tower Research Capital LLC TRC increased its holdings in shares of Teladoc Health by 58.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 22,481 shares of the health services provider's stock worth $196,000 after buying an additional 8,254 shares during the last quarter. Corient Private Wealth LLC increased its holdings in shares of Teladoc Health by 30.4% during the 2nd quarter. Corient Private Wealth LLC now owns 17,180 shares of the health services provider's stock worth $149,000 after buying an additional 4,004 shares during the last quarter. Finally, Manhattan West Asset Management LLC acquired a new stake in Teladoc Health in the 2nd quarter valued at $100,000. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.